Amerigen Pharma

Biopharma acquisitions slow, but it's not Covid-19's fault yet
EP Vantage
Wed, 04/8/20 - 10:28 am
M&A
COVID-19
Gilead Sciences
Forty Seven
Eli Lilly
Dermira
Takeda
Hypera Pharma
ANI Pharmaceuticals
Amerigen Pharma
Amerigen files ANDA for generic version of Bystolic with US FDA
Pharmabiz
Sat, 03/17/12 - 12:19 pm
Amerigen Pharma
China Biotech Week In Review: SFDA Releases 2010 Approval Data
Seeking Alpha
Sun, 10/23/11 - 11:58 am
China
Zhuhai Hokai Medical Instruments
Simcere
Amerigen Pharma
Lundbeck
Medicilon
Shenzhen Hepalink Pharmaceutical